Iguratimod efficacy in palindromic rheumatism treatment

BACKGROUND: As a new immunomodulator for rheumatoid arthritis, iguratimod (IGU) also has therapeutic potential in other immune diseases. In this study, we determined the effects of IGU on disease control in patients with palindromic rheumatism (PR). METHODS: Patients with PR were divided into Contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Fangfang, He, Junhong, Luo, Jing, Zhang, Xin, Lin, Jixia, Chen, Yahui, Huang, Haiyan, Yang, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303674/
https://www.ncbi.nlm.nih.gov/pubmed/37382250
http://dx.doi.org/10.1002/iid3.932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303674/
https://www.ncbi.nlm.nih.gov/pubmed/37382250
http://dx.doi.org/10.1002/iid3.932

Ejemplares similares